Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Cerilliant
Baxter
Chinese Patent Office
Queensland Health
QuintilesIMS
Mallinckrodt
Colorcon
US Army
Cantor Fitzgerald

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040235

« Back to Dashboard

NDA 040235 describes PHENTOLAMINE MESYLATE, which is a drug marketed by Precision Dose Inc and West-ward Pharms Int and is included in two NDAs. It is available from three suppliers. Additional details are available on the PHENTOLAMINE MESYLATE profile page.

The generic ingredient in PHENTOLAMINE MESYLATE is phentolamine mesylate. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the phentolamine mesylate profile page.
Summary for 040235
Tradename:PHENTOLAMINE MESYLATE
Applicant:West-ward Pharms Int
Ingredient:phentolamine mesylate
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 040235
Mechanism of ActionAdrenergic alpha-Antagonists
Medical Subject Heading (MeSH) Categories for 040235
Suppliers and Packaging for NDA: 040235
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PHENTOLAMINE MESYLATE phentolamine mesylate INJECTABLE;INJECTION 040235 ANDA West-Ward Pharmaceuticals Corp 0143-9564 N 0143-9564-10
PHENTOLAMINE MESYLATE phentolamine mesylate INJECTABLE;INJECTION 040235 ANDA West-Ward Pharmaceuticals Corp 0143-9564 N 0143-9564-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength5MG/VIAL
Approval Date:Mar 11, 1998TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Baxter
Express Scripts
Fuji
Argus Health
Healthtrust
QuintilesIMS
Queensland Health
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot